Zobrazeno 1 - 10
of 254
pro vyhledávání: '"Xin Rong Yang"'
Autor:
De-Zhen Guo, Xin Zhang, Sen-Quan Zhang, Shi-Yu Zhang, Xiang-Yu Zhang, Jia-Yan Yan, San-Yuan Dong, Kai Zhu, Xin-Rong Yang, Jia Fan, Jian Zhou, Ao Huang
Publikováno v:
Molecular Cancer, Vol 23, Iss 1, Pp 1-18 (2024)
Abstract Background Tumor heterogeneity presents a formidable challenge in understanding the mechanisms driving tumor progression and metastasis. The heterogeneity of hepatocellular carcinoma (HCC) in cellular level is not clear. Methods Integration
Externí odkaz:
https://doaj.org/article/5bab73eed7a64bc1ad8a6db34ea7804a
Autor:
Fei Song, Bo Hu, Xiao‐Liang Liang, Jian‐Wen Cheng, Cheng‐Gui Wang, Peng‐Xiang Wang, Tian‐Lun Wang, Peng‐Ju Tang, Hai‐Xiang Sun, Wei Guo, Jian Zhou, Jia Fan, Zhong Chen, Xin‐Rong Yang
Publikováno v:
Clinical and Translational Medicine, Vol 14, Iss 8, Pp n/a-n/a (2024)
Abstract Background The therapeutic potential of immune checkpoint blockade (ICB) extends across various cancers; however, its effectiveness in treating hepatocellular carcinoma (HCC) is frequently curtailed by both inherent and developed resistance.
Externí odkaz:
https://doaj.org/article/3dd8c34b8b48459b8232960dbaec05f4
Autor:
De‐Zhen Guo, Ao Huang, Ying‐Chao Wang, Shuang Zhou, Hui Wang, Xiang‐Lei Xing, Shi‐Yu Zhang, Jian‐Wen Cheng, Ke‐Hui Xie, Qi‐Chang Yang, Cheng‐Cheng Ma, Qing Li, Yan Chen, Zhi‐Xi Su, Jia Fan, Rui Liu, Xiao‐Long Liu, Jian Zhou, Xin‐Rong Yang
Publikováno v:
Clinical and Translational Medicine, Vol 14, Iss 5, Pp n/a-n/a (2024)
Abstract Background Early diagnosis of hepatocellular carcinoma (HCC) can significantly improve patient survival. We aimed to develop a blood‐based assay to aid in the diagnosis, detection and prognostic evaluation of HCC. Methods A three‐phase m
Externí odkaz:
https://doaj.org/article/1701daf960ec4386839139f6dbdb08e8
Autor:
Guo-Ming Shi, Xiao-Yong Huang, Dong Wu, Hui-Chuan Sun, Fei Liang, Yuan Ji, Yi Chen, Guo-Huan Yang, Jia-Cheng Lu, Xian-Long Meng, Xin-Ying Wang, Lei Sun, Ning-Ling Ge, Xiao-Wu Huang, Shuang-Jian Qiu, Xin-Rong Yang, Qiang Gao, Yi-Feng He, Yang Xu, Jian Sun, Zheng-Gang Ren, Jia Fan, Jian Zhou
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 8, Iss 1, Pp 1-10 (2023)
Abstract Advanced intrahepatic cholangiocarcinoma (ICC) has a dismal prognosis. Here, we report the efficacy and safety of combining toripalimab, lenvatinib, and gemcitabine plus oxaliplatin (GEMOX) as first-line therapy for advanced ICC. Thirty pati
Externí odkaz:
https://doaj.org/article/6f29477f8ecc4e3a86a2432ea36affb9
Autor:
Xin-Rong Yang, Shuang Jiang, Chun-Li Gan, Jing Huang, Fan-Shu Wei, Zheng-Yang Wang, He-Song Peng, Jing Yang, Chun-Juan Yang
Publikováno v:
World Journal of Traditional Chinese Medicine, Vol 9, Iss 1, Pp 43-52 (2023)
Objective: This study was designed to develop a method for detecting differences in the chemical composition of Corydalis yanhusuo W. T. Wang using high-performance liquid chromatography with a diode array detector technology. Materials and Methods:
Externí odkaz:
https://doaj.org/article/7eafe6c4614c4d7d99eac82dde585ca7
Autor:
An-Li Jin, Lin Ding, Wen-Jing Yang, Te Liu, Wei Chen, Tong Li, Chun-Yan Zhang, Bai-Shen Pan, Shuang-Jian Qiu, Jian Zhou, Jia Fan, Wei Guo, Xin-Rong Yang, Bei-Li Wang
Publikováno v:
BMC Gastroenterology, Vol 22, Iss 1, Pp 1-14 (2022)
Abstract Background Hepatocellular carcinoma (HCC) is the sixth most commonly diagnosed cancer and third leading cause of cancer-related death worldwide in 2020. Exosomes derived from cancer-associated fibroblasts (CAFs-exo) can promote tumor progres
Externí odkaz:
https://doaj.org/article/b59552cb855041b78d512feb0c6fe67b
Autor:
Shao-Lai Zhou, Zheng-Jun Zhou, Cheng-Li Song, Hao-Yang Xin, Zhi-Qiang Hu, Chu-Bin Luo, Yi-Jie Luo, Jia Li, Zhi Dai, Xin-Rong Yang, Ying-Hong Shi, Zheng Wang, Xiao-Wu Huang, Jia Fan, Jian Zhou
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 7, Iss 1, Pp 1-17 (2022)
Abstract Patients with hepatocellular carcinoma (HCC) have poor long-term survival following curative resection because of the high rate of tumor early recurrence. Little is known about the trajectory of genomic evolution from primary to early-recurr
Externí odkaz:
https://doaj.org/article/f0a7af90e44446f1b0b15156fc8c796b
Autor:
De-Zhen Guo, Shi-Yu Zhang, San-Yuan Dong, Jia-Yan Yan, Yu-Peng Wang, Ya Cao, Sheng-Xiang Rao, Jia Fan, Xin-Rong Yang, Ao Huang, Jian Zhou
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundImmune checkpoint inhibitor (ICI)-based combination therapy has opened a new avenue for the treatment of multiple malignancies including hepatocellular carcinoma (HCC). However, considering the unsatisfactory efficacy, biomarkers are urgent
Externí odkaz:
https://doaj.org/article/b408a1ff6a804c38932bd524141c85a0
Autor:
De-Zhen Guo, Shi-Yu Zhang, San-Yuan Dong, Jia-Yan Yan, Yu-Peng Wang, Ya Cao, Sheng-Xiang Rao, Jia Fan, Xin-Rong Yang, Ao Huang, Jian Zhou
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundLenvatinib monotherapy and combination therapy with immune checkpoint inhibitors (ICI) were widely applied for unresectable hepatocellular carcinoma (uHCC). However, many patients failed to benefit from the treatments. A prognostic model wa
Externí odkaz:
https://doaj.org/article/56079ece69b04b749806519d91bd529f
Autor:
Peng‐Xiang Wang, Yun‐Fan Sun, Wei‐Xiang Jin, Jian‐Wen Cheng, Hai‐Xiang Peng, Yang Xu, Kai‐Qian Zhou, Li‐Meng Chen, Kai Huang, Sui‐Yi Wu, Bo Hu, Ze‐Fan Zhang, Wei Guo, Ya Cao, Jian Zhou, Jia Fan, Xin‐Rong Yang
Publikováno v:
Molecular Oncology, Vol 15, Iss 9, Pp 2345-2362 (2021)
Circulating tumor cell (CTC) analysis holds great potential to be a noninvasive solution for clinical cancer management. A complete workflow that combined CTC detection and single‐cell molecular analysis is required. We developed the ChimeraX®‐i
Externí odkaz:
https://doaj.org/article/0404e2d999594741806a47d454e262e2